1/2
Genabio
Genabio Covid-19 Rapid Self-Test
1 ct
$10.18 each($10.18 / each)
Aisle 34
Victoria H‑E‑B plus!
6106 N. NAVARRO
Description
Emergency use authorization. FDA.
1x COVID-19 test card; 1x swab; 1x pre filled tube.
1x instruction for use.
At home result in 15 mins.
The Genabio COVID-19 Rapid Self-Test Kit is a lateral flow chromatographic immunoassay method intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in anterior nasal swab specimens directly from individuals within 7 days of symptom onset or without symptoms or other epidemiological reasons to suspect COVID-19.
For in vitro diagnostic use.
For use under the Emergency Use Authorization (EUA) only.
For ages 2 through 13, an adult Must collect and test the anterior nares specimen.
This test does not determine if you had COVID-19 in the past or if you have immunity.
You can use a single test, if you have any symptoms of COVID-19.
If you do not have symptoms of COVID-19, you will need at least two tests per person.
You may need to purchase additional tests to perform serial (repeat) testing.
This test is more likely to give you a false negative result when you have COVID-19 than a lab-based molecular test.
This product has not been FDA cleared or approved but has been authorized by FDA under an Emergency Use Authorization (EUA).
This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens.
The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. QC Passed. Scan and verify the authenticity. Made in China.
1x COVID-19 test card; 1x swab; 1x pre filled tube.
1x instruction for use.
At home result in 15 mins.
The Genabio COVID-19 Rapid Self-Test Kit is a lateral flow chromatographic immunoassay method intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in anterior nasal swab specimens directly from individuals within 7 days of symptom onset or without symptoms or other epidemiological reasons to suspect COVID-19.
For in vitro diagnostic use.
For use under the Emergency Use Authorization (EUA) only.
For ages 2 through 13, an adult Must collect and test the anterior nares specimen.
This test does not determine if you had COVID-19 in the past or if you have immunity.
You can use a single test, if you have any symptoms of COVID-19.
If you do not have symptoms of COVID-19, you will need at least two tests per person.
You may need to purchase additional tests to perform serial (repeat) testing.
This test is more likely to give you a false negative result when you have COVID-19 than a lab-based molecular test.
This product has not been FDA cleared or approved but has been authorized by FDA under an Emergency Use Authorization (EUA).
This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens.
The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. QC Passed. Scan and verify the authenticity. Made in China.